Short Interspersed Nuclear Elements (SINEs) are non-autonomous retrotransposons that comprise a large fraction of the human genome. SINEs are demethylated in human disease, but whether SINEs become transcriptionally induced and how the resulting transcripts may affect the expression of protein coding genes is unknown. Here, we show that downregulation of the mRNA of the tumor suppressor gene BRCA1 is associated with increased transcription of SINEs and production of sense and antisense SINE small RNAs. We find that BRCA1 mRNA is post-transcriptionally down-regulated in a Dicer and Drosha dependent manner and that expression of a SINE inverted repeat with sequence identity to a BRCA1 intron is sufficient for downregulation of BRCA1 mRNA. These observations suggest that transcriptional activation of SINEs could contribute to a novel mechanism of RNA mediated post-transcriptional silencing of human genes.
References
[1]
Martienssen, R.A.; Colot, V. DNA methylation and epigenetic inheritance in plants and filamentous fungi. Science 2001, 293, 1070–1074, doi:10.1126/science.293.5532.1070.
Carmell, M.A.; Girard, A.; van de Kant, H.J.; Bourc'his, D.; Bestor, T.H.; de Rooij, D.G.; Hannon, G.J. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell. 2007, 12, 503–514, doi:10.1016/j.devcel.2007.03.001.
Chenais, B. Transposable elements and human cancer: A causal relationship? Biochim. Biophys. Acta. 2012, 1835, 28–35.
[12]
Waterland, R.A.; Jirtle, R.L. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 2003, 23, 5293–5300.
[13]
Wolff, E.M.; Byun, H.M.; Han, H.F.; Sharma, S.; Nichols, P.W.; Siegmund, K.D.; Yang, A.S.; Jones, P.A.; Liang, G. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet. 2010, 6, e1000917, doi:10.1371/journal.pgen.1000917.
[14]
Hasler, J.; Strub, K. Alu elements as regulators of gene expression. Nucleic Acids Res. 2006, 34, 5491–5497, doi:10.1093/nar/gkl706.
[15]
Cordaux, R.; Batzer, M.A. The impact of retrotransposons on human genome evolution. Nat. Rev. Genet. 2009, 10, 691–703, doi:10.1038/nrg2640.
[16]
Walters, R.D.; Kugel, J.F.; Goodrich, J.A. InvAluable junk: The cellular impact and function of Alu and B2 RNAs. IUBMB Life 2009, 61, 831–837, doi:10.1002/iub.227.
[17]
Thompson, M.E.; Jensen, R.A.; Obermiller, P.S.; Page, D.L.; Holt, J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 1995, 9, 444–450.
[18]
Catteau, A.; Xu, C.F.; Brown, M.A.; Hodgson, S.; Greenman, J.; Mathew, C.G.; Dunning, A.M.; Solomon, E. Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions. Br. J. Cancer 1999, 79, 759–763, doi:10.1038/sj.bjc.6690122.
[19]
Catteau, A.; Harris, W.H.; Xu, C.F.; Solomon, E. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999, 18, 1957–1965, doi:10.1038/sj.onc.1202509.
[20]
Girardi, A.J.; Weinstein, D.; Moorhead, P.S. SV40 transformation of human diploid cells. A parallel study of viral and karyologic parameters. Ann. Med. Exp. Biol. Fenn. 1966, 44, 242–254.
[21]
Stampfer, M.; Hallowes, R.C.; Hackett, A.J. Growth of normal human mammary cells in culture. In Vitro 1980, 16, 415–425, doi:10.1007/BF02618365.
[22]
Soule, H.D.; Maloney, T.M.; Wolman, S.R.; Peterson, W.D., Jr.; Brenz, R.; McGrath, C.M.; Russo, J.; Pauley, R.J.; Jones, R.F.; Brooks, S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990, 50, 6075–6086.
[23]
Cailleau, R.; Young, R.; Olivé, M.; Reeves, W.J., Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 1974, 53, 661–674.
[24]
Soule, H.D.; Vazguez, J.; Long, A.; Albert, S.; Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 1973, 51, 1409–1416.
[25]
Trent, J.; Yang, J.M.; Emerson, J.; Dalton, W.; McGee, D.; Massey, K.; Thompson, F.; Villar, H. Clonal chromosome abnormalities in human breast carcinomas. I. Twenty-eight cases with primary disease. Genes Chromosomes Cancer 1993, 7, 185–193, doi:10.1002/gcc.2870070402.
[26]
Meltzer, P.; Leibovitz, A.; Dalton, W.; Villar, H.; Kute, T.; Davis, J.; Nagle, R.; Trent, J. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br. J. Cancer 1991, 63, 727–735, doi:10.1038/bjc.1991.164.
[27]
Engel, L.W.; Young, N.A.; Tralka, T.S.; Lippman, M.E.; O'Brien, S.J.; Joyce, M.J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 1978, 38, 3352–3364.
[28]
Alleman, M.; Sidorenko, L.; McGinnis, K.; Seshadri, V.; Dorweiler, J.E.; White, J.; Sikkink, K.; Chandler, V.L. An RNA-dependent RNA polymerase is required for paramutation in maize. Nature 2006, 442, 295–298, doi:10.1038/nature04884.
[29]
Dorweiler, J.E.; Carey, C.C.; Kubo, K.M.; Hollick, J.B.; Kermicle, J.L.; Chandler, V.L. Mediator of paramutation1 is required for establishment and maintenance of paramutation at multiple maize loci. Plant. Cell. 2000, 12, 2101–2118.
[30]
Davoren, P.A.; McNeill, R.E.; Lowery, A.J.; Kerin, M.J.; Miller, N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol. Biol. 2008, 9, 76, doi:10.1186/1471-2199-9-76.
[31]
Xu, C.F.; Chambers, J.A.; Solomon, E. Complex regulation of the BRCA1 gene. J. Biol. Chem. 1997, 272, 20994–20997, doi:10.1074/jbc.272.34.20994.
[32]
Rice, J.C.; Massey-Brown, K.S.; Futscher, B.W. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene. 1998, 17, 1807–1812.
[33]
Birney, E.; Stamatoyannopoulos, J.A.; Dutta, A.; Guigó, R.; Gingeras, T.R.; Margulies, E.H.; Weng, Z.; Snyder, M.; Dermitzakis, E.T.; Thurman, R.E. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447, 799–816, doi:10.1038/nature05874.
[34]
Ah-Fong, A.M.; Bormann-Chung, C.A.; Judelson, H.S. Optimization of transgene-mediated silencing in Phytophthora infestans and its association with small-interfering RNAs. Fungal Genet. Biol. 2008, 45, 1197–1205.
[35]
Kadotani, N.; Nakayashiki, H.; Tosa, Y.; Mayama, S. RNA silencing in the phytopathogenic fungus Magnaporthe oryzae. Mol. Plant. Microbe Interact. 2003, 16, 769–776, doi:10.1094/MPMI.2003.16.9.769.
